Original articleInhibition of endoplasmic reticulum stress and oxidative stress by vitamin D in endothelial cells
Introduction
Coronary artery disease is the leading cause of mortality in the United States [1]. Several risk factors predict the development of coronary artery disease, including dyslipidemia and the presence of diabetes, obesity, and the metabolic syndrome [2], [3], [4]. Recently, several studies have shown that plasma vitamin D levels are inversely correlated with atherosclerosis [5], [6], [7]. While it is not clear how vitamin D impacts the development of coronary artery disease, several studies have indicated that part of the mechanism may involve vitamin D's effects on immune cells, especially macrophages [8], [9]. In some trials however, treatment of vitamin d-deficient patients with vitamin D had little or no effect on lowering triglyceride, low-density lipoprotein (LDL) and total cholesterol levels, and raising high-density lipoprotein levels [10], [11].
Endothelial cells form an essential barrier function and are involved in regulating the passage of plasma constituents and immune cells into the extravascular space. Pro-inflammatory cytokines, free-fatty acids, and hyperglycemia have been shown to induce intracellular stress responses in endothelial cells, promoting oxidative stress and endoplasmic reticulum (ER) stress, as well as the production of chemo-attractant molecules such as monocyte chemo-attractant protein-1 (MCP-1), intercellular adhesion molecule 1 (ICAM 1), and vascular cell adhesion molecule 1 (VCAM 1) [12], [13], [14], [15]. Extravasation of monocytes and passage of oxidized LDL through a damaged endothelium allows for the formation of lipid-laden foam cells. Access to the sub-endothelial space also allows for activation of clotting and complement-based injury.
Several circulating factors have been shown to have favorable effects on endothelial barrier function. Antioxidants, estradiol, testosterone, and high-density lipoprotein (HDL) have been shown to inhibit oxidative stress, ER stress, chemo-attractant molecule expression [16], [17], [18], while promoting NO release and relaxation of vascular tone [19], [20]. Since elevated plasma vitamin D levels are inversely correlated with atherosclerosis and cardiovascular disease, we assessed the ability of vitamin D to inhibit ER stress and hyperglycemia-induced oxidative in human primary endothelial cells.
Section snippets
Materials
1,25-dihydroxy vitamin D3 (1,25-(OH)2D3), 25-hydroxyvitamin D3 (25-OHD3), and 24,25-dihydroxyvitamin D3 (24,25-(OH)2D3) were obtained from Sigma-Aldrich (St. Louis, MO.) The chemiluminescent alkaline phosphatase substrate 3-(diethylamino)-1-(2,2-dimethyl-3-H-1-benzofuran-7-yl)-propan-1-one (CSPD) was purchased from Clontech Laboratories, Inc. (Mountain View, CA). Lipofectamine and hydroethidine were obtained from Invitrogen (Carlsbad, CA.) Tunicamycin (TM) was purchased from Cayman Chemical
The effect of 1,25-(OH)2D3 on ER stress
To determine if 1,25-(OH)2D3 inhibit ER stress, HUVEC were transfected with pSEAP2.Control and treated with 0.1 μM TM and 50 nM 1,25-(OH)2D3, for 24-h (Fig. 1A). Treatment with TM decreased SEAP activity from 65,332±6183 relative light units (R.L.U.) to 6830±328 R.L.U. (p<0.0001). However, in the presence of 1,25-(OH)2D3, SEAP expression increased from 6830±328 R.L.U. to 16,581±1297 R.L.U.; p<0.0003, relative to TM-treated cells. These results suggest that 1,25-(OH)2D3 inhibits TM induced ER stress
Discussion
Several forms of cell stress have been shown to have critical roles in the initiation and progression of coronary artery disease. Oxidative stress and ER stress have both been implicated in promoting cell death, tissue damage, and organ dysfunction. Though antioxidants have been promoted and tested in clinical trials, they have not been effective at preventing the vascular dysfunction associated with coronary artery disease. This may be due to the presence of either intracellular oxidative
Acknowledgements
We would like to thank Jessica VanOmmeren, Elysia Heilig, Jessie Wang, and Sophie Wang for their assistance in the laboratory. We wish to acknowledge Schering AG (Berlin, Germany) for their generosity in providing the ZK-191784 and LEO Pharma A/S (Ballerup, Denmark) for their generosity in providing the EB1089. This work was funded by a grant from the University of Florida (Grant no. 70740) – Jacksonville.
References (38)
The forgotten majority: unfinished business in cardiovascular risk reduction
J. Am. Coll. Cardiol.
(2005)- et al.
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials
Lancet
(2010) - et al.
Vitamin D suppression of endoplasmic reticulum stress promotes an anti-atherogenic monocyte/macrophage phenotype in type 2 diabetic patients
J. Biol. Chem.
(2012) - et al.
Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells
Nutrition
(2010) - et al.
Effects of antioxidants on glucose-induced oxidative stress and endoplasmic reticulum stress in endothelial cells
Diabetes Res. Clin. Pract.
(2010) - et al.
Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cells
Free Radic. Biol. Med.
(2012) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
Anal. Biochem.
(1976)- et al.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Anal. Biochem.
(1987) - et al.
Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women
J. Nutr.
(2013) - et al.
Endothelial relaxation mechanisms and nitrative stress are partly restored by Vitamin D3 therapy in a rat model of polycystic ovary syndrome
Life Sci.
(2013)
Vitamin D reduces deposition of advanced glycation end-products in the aortic wall and systemic oxidative stress in diabetic rats
Diabetes Res. Clin. Pract.
Dissecting glycoprotein biosynthesis by the use of specific inhibitors
Biochimie
Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 eiabetic patients
J. Biol. Chem.
American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics−2014 update: a report from the American Heart Association
Circulation
Emerging economies and diabetes and cardiovascular disease
Diabetes Technol. Ther.
Vitamin D and cardiovascular disease
Curr. Vasc. Pharmacol.
Vitamin D and the cardiovascular system
Clin. J. Am. Soc. Nephrol.
Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyviatmin D levels with all-cause mortality and cardiovascular mortality
Arch. Intern. Med.
1,25-(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus
Circulation
Cited by (55)
Microbial bile acid metabolite ameliorates mycophenolate mofetil-induced gastrointestinal toxicity through vitamin D3 receptor
2024, American Journal of TransplantationVitamin D may assist the UPR against sodium fluoride-induced damage by reducing RIPK1, ATG5, BECN1, oxidative stress and increasing caspase-3 in the osteoblast MC3T3-E1 cell line
2023, Journal of Trace Elements in Medicine and BiologyAntioxidants affect endoplasmic reticulum stress-related diseases
2023, Vitamins and HormonesVitamin-D ameliorates sepsis-induced acute lung injury via augmenting miR-149-5p and downregulating ER stress
2022, Journal of Nutritional BiochemistryEndoplasmic reticulum stress: A common pharmacologic target of cardioprotective drugs
2022, European Journal of Pharmacology